CARBOPLATIN

Generic: CARBOPLATIN

HospiraManufacturer
INTRAVENOUSRoute
CARBOPLATINActive Substance
2004-11-23Original Approval

CARBOPLATIN is FDA application ANDA077059, sponsored by HOSPIRA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
OFF LABEL USE
8,796 reports
2
NEUTROPENIA
7,633 reports
3
ANAEMIA
7,391 reports
4
NAUSEA
7,205 reports
5
FEBRILE NEUTROPENIA
6,742 reports
6
DIARRHOEA
6,425 reports
7
MALIGNANT NEOPLASM PROGRESSION
6,347 reports
8
DISEASE PROGRESSION
6,172 reports
9
THROMBOCYTOPENIA
6,085 reports
10
DYSPNOEA
5,535 reports